Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6155883B2 - - Google Patents
[go: Go Back, main page]

JPS6155883B2 - - Google Patents

Info

Publication number
JPS6155883B2
JPS6155883B2 JP8012682A JP8012682A JPS6155883B2 JP S6155883 B2 JPS6155883 B2 JP S6155883B2 JP 8012682 A JP8012682 A JP 8012682A JP 8012682 A JP8012682 A JP 8012682A JP S6155883 B2 JPS6155883 B2 JP S6155883B2
Authority
JP
Japan
Prior art keywords
perfusate
oxygenator
organ
gas
partial pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8012682A
Other languages
Japanese (ja)
Other versions
JPS58198401A (en
Inventor
Yukio Kasuga
Juichi Sasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Priority to JP8012682A priority Critical patent/JPS58198401A/en
Publication of JPS58198401A publication Critical patent/JPS58198401A/en
Publication of JPS6155883B2 publication Critical patent/JPS6155883B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は摘出した臓器の保存装置に関し、さら
に詳細には重炭酸系のPH緩衝剤を含有する液体を
摘出臓器に潅流させることにより臓器の活性を維
持しつつ臓器を保存する摘出臓器の保存装置に関
するものである。 従来、摘出した臓器を潅流液の循環により活性
維持しつつ保存することが知られており、またこ
の潅流液のPHを重炭酸系のPH緩衝剤によりPH調整
することも知られている。潅流液を保存臓器に潅
流させると、この潅流液のPHは経時的に変化し、
最終的に臓器保存に適さなくなる。このため、摘
出臓器をその活性を維持しつつ保存するには、潅
流液のPHを監視すると共に、臓器保存に適するよ
う適宜調整する必要がある。この目的で、従来は
潅流液を経時的にサンプリングしてPH測定を行な
い、その測定値に応じて吹込み炭酸ガスの量を増
減させて潅流液のPHを手動制御する方法、或いは
潅流液中にPH電極を常時浸漬して潅流液のPHが設
定範囲内に保持されるように炭酸ガスを間欠的に
吹込む方法が行なわれていた。しかしながら、前
者はPHの変動幅が大きくかつ手間がかかるという
欠点を有し、後者は操作が煩雑なPH電極を必要と
し、しばしば電極の汚れによりPH測定値に誤まり
を生ずるなどの欠点を有する。 そこで、上記の従来技術に伴なう諸欠点を解消
し、簡便かつ信頼性高く潅流液のPHを制御しうる
ような臓器保存方式が熱望されている。 潅流液により摘出臓器を保存する場合、この潅
流液に重炭酸系のPH緩衝剤を使用すれば、そのPH
は下式(A) PH=6.1+log〔HCO3 -〕/〔CO2〕 ……(A) のヘンダーソン・ハツセルバツハ式に従うことが
知られている。 今回、発明者等は、式(A)において〔HCO3 -〕の
値は潅流液中において殆んど変化せず、したがつ
て潅流液のPHが上記式(A)における〔CO2〕の値
(すなわち、潅流液中のCO2ガス分圧)により一
義的に定まることに着目し、種々検討を重ねた結
果潅流初期〔HCO3 -〕を測定しておけばその後は
潅流液中のCO2ガス分圧を制御するだけで潅流液
のPHを所望する任意の値に設定することができる
ことを突き止め、さらにこの目的で潅流液の回路
中にCO2ガス交換能の高い人工肺、すなわちこの
人工肺のガス側におけるCO2ガス分圧と潅流液中
のCO2ガス分圧とをほぼ等しくしうるような高い
CO2ガス交換能を有する人工肺を配置し、人工肺
ガス側のCO2ガス分圧をCO2ガスと空気との混合
比により調整すれば潅流液のPHを任意所望の値に
簡便かつ信頼性高く制御しうることを突き止め
た。 したがつて、本発明の目的は、摘出臓器に重炭
酸系のPH緩衝剤を含有する液体を潅流させること
により臓器の活性を維持しつつ臓器を保存する簡
便かつ信頼性高い臓器保存装置を提供することに
ある。 この目的は、本発明によれば、重炭酸系のPH緩
衝剤を含有する液体の潅流回路中にCO2ガス交換
能の高い人工肺を設け、この人工肺のガス側にお
けるCO2と空気との混合比を調整することにより
前記液体のPHをオープンループにより制御するよ
う構成することにより達成される。 なお、人工肺のCO2ガス交換能は、潅流液100
ml/min.、当り1cm3/S以上とすべきであり、この
ような交換能を有する限り人工肺は如何なる型式
(たとえば、膜型、コイル型またはホローフアイ
バー型)でもよく、またその材質も適宜選択する
ことができる。 また、本発明の臓器保存装置は、潅流液回路中
に上記構成の人工肺を設ける以外は、当業者に周
知された装置を使用することができる。 以下、添付図面を参照して本発明を実施例につ
きさらに説明する。 本発明による臓器保存装置は潅流液リザーバ1
0と、潅流ポンプ(たとえばローラポンプ)12
と、熱交換器14と、本発明の要部である人工肺
(たとえば膜型肺)16と、フイルタ18を付設
したエアトラツプ20と、動脈カニユーレ部22
と、摘出臓器を保存する臓器保存室24とを順次
配置してなり、これらを閉回路として形成する配
管系を備える。さらに、前記人工肺16には、オ
ープンループとして、CO2と空気との混合ガスを
人工肺に供給する系と人工肺からの排気系(詳細
には図示せず)とを備え、前記供給系は炭酸ガス
源26とエアポンプ(空気供給用)28とをそれ
ぞれガス流量計30,32を介して接続してな
り、これらガス流量計30,32の設定により所
望の混合比に混合されたCO2と空気との混合ガス
を人工肺に供給する配管を備える。なお、潅流液
の温度を制御するには、臓器保存室24内に温度
センサ(図示せず)を設け、熱交換器14に冷水
ジヤケツト34からの冷水を冷却水循環装置36
により循環させることができる。さらに、潅流ポ
ンプ12にポンプ制御部38を設ける一方、エア
トラツプ20に圧力トランジユーサ40を付設す
ると共に増幅器42を設けて、これら検知部およ
び制御部の連携により、潅流液の温度、流量など
を制御することもでき、これらの数値を増幅器4
2を介して表示器44および記録計46にそれぞ
れ表示記録することもできる。 本発明の臓器保存装置を操作するに際し、重炭
酸系のPH緩衝剤を含有する潅流液は、リザーバ1
0から潅流ポンプ12により熱交換器14を介し
て人工肺16に供給される。熱交換器14におい
ては、冷却水循環装置36により循環される冷水
との熱交換により潅流液を所望温度に冷却する。
炭酸ガスと空気との混合ガスが人工肺16に供給
されて、潅流液の酸素加とPH調整とが行なわれた
後、潅流液はフイルタ18、エアートラツプ20
を介して動脈カニユーレ22により摘出保存臓器
に潅流され、次いで臓器からリザーバ10へ還流
される。 本発明の主要部は、上記のように構成した潅流
液回路中に人工肺16(たとえば膜型肺)を配置
し、それにより酸素加を行なうだけでなく、CO2
ガス分圧の制御により潅流液のPH調整をも行なう
点にある。 前記したように、潅流液中に重炭酸系のPH緩衝
剤が含有される場合、潅流液のPHは下式(A) PH=6.1+log〔HCO3 -〕/〔CO2〕 ……(A) のヘンダーソン・ハツセルバツハ式に従つて変化
し、〔HCO3 -〕の値は潅流中において殆んど変化
しないため、PHは潅流液中の〔CO2)の値により
一義的に定まることが判るであろう。したがつ
て、潅流期間の初期にのみ潅流液中の
〔HCO3 -〕値を測定すれば、その後は潅流液中の
CO2ガス分圧だけを制御することによりPHを決定
しうることも判るであろう。この観点から、人工
肺のガス供給側におけるCO2ガス分圧と潅流液中
におけるCO2ガス分圧とがほぼ等しくなりうるよ
うなCO2ガス交換能の高い人工肺を用い、CO2
空気との混合比(すなわち混合ガス中のCO2ガス
分圧)を調整することにより潅流液のPHを所望値
に設定するよう構成したものが本発明の臓器保存
装置である。 ここで、本発明を理論的に考察すれば次の通り
である。 先ず、潅流液中のCO2ガス分圧(以下、Pco2
表わす)は、 (1) 人工肺でガス交換されるCO2量:V1 (2) 潅流回路中の臓器保存室およびリザーバから
の大気中に放散されるCO2量:V2 (3) 保存臓器より産出されるCO2量:V3 によつて影響される。この場合、潅流液は循環さ
れているので或る値において平衡に達する。これ
らの関係を式で示せば次の通りである: V1=k1×S1×(PG−PL)/760×α ……(B) V2=k2×S2×(−PL)/760×α ……(C) V3=微小であるため無視しうる。 〔式中、k1は人工肺におけるCO2交換係数(cm/
S)、 k2は液と大気との間のCO2交換係数(約5×
10-4cm/S以下)、 S1は人工肺の膜面積(cm2) S2は潅流液と大気との接触面積(潅流液は通常
1程度であり、接触面積は最大200cm2程度であ
る)、 PLは潅流液中のPco2が平衡状態に達した時の
CO2ガス分圧〔mmHg〕、 PGは人工肺のガス側におけるPco2〔mmHg〕、 αはCO2溶解度〔ml/ml.atom〕(8℃の時、
1.18ml/ml.atom)である〕。 さらに、潅流液のPco2が平衡に達した後は次式
(D) V1+V2+V3=0 ……(D) の関係が成立し、ここでV3は上記したように微
小で無視しうるため、 V1+V2≒0 ……(D′) となる。上記式(D′)におけるV1およびV2にそ
れぞれ上記式(B)および(C)を代入すると、下式(B)が
得られる: k1×S1×(PG−PL)/760×1.18 −5×10-4×200×PL/760×1.18=0 ∴PG/PL=(10-1×k1S1)/k1S1 ……(E) ここで、PL(人工肺液側CO2分圧)は、人工
肺ガス交換能が高くなるほどPG(人工肺ガス側
CO2分圧)の値に近づくが、全く同じ値になるこ
とはない。もしPLがPGに等しくなつたと仮定
し、その時のCO2モル濃度を〔CO2〕′とすれ
ば、潅流液のPH′はヘンダーソン・ハツセルバツ
ハの式(A)に従つて PH′=6.1+log〔HCO3 -〕/〔CO2〕′ 〔PG=PLの時のPH目標値〕 で表わされる。また、実際の人工肺液側CO2分圧
がPLである時のCO2モル濃度を〔CO2〕″とすれ
ば、その時の潅流液のPH″は同様にヘンダーソ
ン・ハツセルバツハ式に従つて PH″=6.1+log〔HCO3 -〕/〔CO2〕″ 〔潅流液の実際のPH値〕 で表わされる。 潅流液のPHは、生理的な観点から、PH目標値に
対し僅少の偏差内に収めることが望ましい。そこ
でPH目標値と実際のPH値との間の偏差をεとすれ
ば、 |PH″−PH′|=ε PH″およびPH′にそれぞれ上記両ヘンダーソン・
ハツセルバツハ式を代入して、式 log〔CO2〕′/〔CO2〕″=±ε を得る。かくして、式 logPG/PL=±ε ∴PG/PL=10±〓 となる。もし偏差εを0.05以内に収めるとすれ
ば、すなわちPHの誤差を0.05以内とするには、上
記式においてε0.05であるから PG/PL100.05 ∴PG/PL1.1 ……(F) とすればよい。したがつて、式(E)および(F)から、 10-1+k1S11.1×k1S1 ∴k1S11 となる。ここで、k1S1は本発明に使用する人工肺
のガス交換能に他ならない。 以上の理論的考察から判るように、潅流液のPH
を0.05以内の精度で設定するには、人工肺のCO2
ガス交換能を潅流液100ml/min当り1cm3/Sとすべ
きである。 このように本発明によれば、潅流液のPHを、煩
雑なPH電極を使用したり或いは経時的にPHを測定
することなくCO2と空気との混合比(すなわち人
工肺のガス側におけるCO2ガス分圧)を調整する
だけで、任意所望の値に設定することができるの
で、潅流液による摘出臓器の保存において極めて
有利である。 上記の構成による本発明は次のように実施する
ことができる。 先ず、前記ヘンダーソン・ハツセルバツハ式に
よれば、 PH=6.1+log〔HCO3 -〕/〔CO2〕 ……(A) であり、この式(A)から式 〔CO2〕=〔HCO3 -〕 ×10(6.1-PH)〔mol/〕 ……(A′) が誘導される。この式(A′)の〔CO2〕を温度t
℃の時のガス分圧に換算すると、下式(G) Pco2(t℃)=〔CO〕〔mol/l〕×10−3〔/ml〕/αt〔ml(G)/ml(L).atm〕 ×22.4×103〔ml(G)/mol〕×760〔mmHg/atm〕 ……(G) 〔式中、ml(L)は水溶液の体積、 ml(G)はCO2の体積、 αtはt℃におけるCO2の溶解度である〕 が得られる。さらに人工肺のガス側におけるCO2
ガス分圧(Pco2)と空気および炭酸ガスの流量
(Qair、Qco2)については次の関係式(H)および
(H′)が成立する。 Qair:Qco2=(760−Pco2):Pco2 ……(H) Qco2=Qair×Pco2/(760−Pco2) ……(H′) 上記式(A′)、(G)および(H′)より下式(I) Qco2(t℃)=〔HCO 〕×10(61−PH×22.4×760/αt/760−〔HCO 〕×10
1−PH×22.4×760/αt(ml/min.〕……(I) が誘導される。上記式(I)に目標PH値、〔HCO3 -
値および各温度における溶解度αをそれぞれ代入
して下記の第1表が得られた。
The present invention relates to a device for preserving an excised organ, and more particularly, a device for preserving an excised organ that preserves the organ while maintaining its activity by perfusing the excised organ with a liquid containing a bicarbonate-based PH buffer. It is related to. Conventionally, it has been known to preserve removed organs while maintaining their activity by circulating a perfusate, and it is also known to adjust the pH of this perfusate using a bicarbonate-based PH buffer. When a perfusate is perfused into a preserved organ, the pH of this perfusate changes over time,
Eventually, the organ becomes unsuitable for preservation. Therefore, in order to preserve the excised organ while maintaining its activity, it is necessary to monitor the pH of the perfusate and adjust it appropriately to make it suitable for organ preservation. Conventionally, for this purpose, the PH of the perfusate is manually controlled by sampling the perfusate over time and measuring the pH of the perfusate, and increasing or decreasing the amount of carbon dioxide injected according to the measured value, or The method used was to constantly immerse a PH electrode in the perfusate and inject carbon dioxide intermittently to maintain the PH of the perfusate within a set range. However, the former has the disadvantage that the range of PH fluctuation is large and is time-consuming, while the latter requires a PH electrode that is complicated to operate, and has the disadvantage that the PH measurement value often causes errors due to dirt on the electrode. . Therefore, there is a desire for an organ preservation method that eliminates the various drawbacks associated with the above-mentioned conventional techniques and that can easily and reliably control the PH of the perfusate. When preserving the excised organ with a perfusate, using a bicarbonate-based PH buffer in the perfusate will reduce its pH.
It is known that the formula (A) PH=6.1+log[HCO 3 - ]/[CO 2 ] follows the Henderson-Hatsselbach equation (A). This time, the inventors found that the value of [HCO 3 - ] in formula (A) hardly changes in the perfusate, and therefore the PH of the perfusate is the same as that of [CO 2 ] in formula (A). We focused on the fact that it is uniquely determined by the CO 2 gas partial pressure in the perfusate, and after various studies, we found that if we measure the initial stage of perfusion [HCO 3 - ], then the CO 2 gas in the perfusate can be measured. 2 It was found that the PH of the perfusate could be set to any desired value simply by controlling the gas partial pressure, and for this purpose an oxygenator with a high CO 2 gas exchange capacity was installed in the perfusate circuit, i.e., this High enough to make the CO 2 gas partial pressure on the gas side of the oxygenator approximately equal to the CO 2 gas partial pressure in the perfusate.
By placing an oxygenator with CO 2 gas exchange ability and adjusting the CO 2 gas partial pressure on the oxygenator gas side by adjusting the mixture ratio of CO 2 gas and air, the PH of the perfusate can be easily and reliably adjusted to any desired value. We have discovered that it is highly controllable. Therefore, an object of the present invention is to provide a simple and highly reliable organ preservation device that preserves organs while maintaining organ activity by perfusing extracted organs with a liquid containing a bicarbonate-based PH buffer. It's about doing. According to the present invention, an oxygenator with a high CO 2 gas exchange capacity is provided in the perfusion circuit of a liquid containing a bicarbonate-based PH buffer, and CO 2 and air are exchanged on the gas side of this oxygenator. This is achieved by controlling the pH of the liquid in an open loop by adjusting the mixing ratio of the liquid. In addition, the CO 2 gas exchange capacity of the oxygenator is
The oxygen exchange rate should be 1 cm 3 /S or more per ml/min., and the oxygenator may be of any type (for example, membrane type, coil type, or hollow fiber type) as long as it has this exchange capacity, and its material may also be It can be selected as appropriate. Furthermore, the organ preservation device of the present invention can use any device well known to those skilled in the art, except for providing the oxygenator having the above configuration in the perfusate circuit. Hereinafter, the invention will be further explained by way of example with reference to the accompanying drawings. The organ preservation device according to the invention includes a perfusion fluid reservoir 1
0 and an irrigation pump (e.g. roller pump) 12
, a heat exchanger 14, an oxygenator (for example, a membrane lung) 16, which is a main part of the present invention, an air trap 20 equipped with a filter 18, and an arterial cannula 22.
and an organ preservation chamber 24 for preserving the extracted organ, and are provided with a piping system that forms these as a closed circuit. Furthermore, the oxygenator 16 is equipped with an open loop system for supplying a mixed gas of CO 2 and air to the oxygenator and an exhaust system (not shown in detail) from the oxygenator, and the supply system is formed by connecting a carbon dioxide gas source 26 and an air pump (for air supply) 28 via gas flowmeters 30 and 32, respectively, and CO 2 mixed to a desired mixing ratio by the settings of these gas flowmeters 30 and 32. It is equipped with piping that supplies a mixed gas of air and air to the oxygenator. In order to control the temperature of the perfusate, a temperature sensor (not shown) is provided in the organ storage chamber 24, and the cold water from the cold water jacket 34 is transferred to the heat exchanger 14 through the cooling water circulation device 36.
It can be circulated by Furthermore, the perfusion pump 12 is provided with a pump control section 38, while the air trap 20 is provided with a pressure transducer 40 and an amplifier 42, and the temperature, flow rate, etc. of the perfusion fluid are controlled by the cooperation of these detection sections and control sections. You can also input these values to amplifier 4.
It is also possible to display and record the information on the display 44 and the recorder 46 via 2. When operating the organ preservation device of the present invention, a perfusion solution containing a bicarbonate-based PH buffer is added to the reservoir 1.
0 to the oxygenator 16 via the heat exchanger 14 by the perfusion pump 12. In the heat exchanger 14, the irrigation fluid is cooled to a desired temperature by heat exchange with cold water circulated by the cooling water circulation device 36.
A mixed gas of carbon dioxide and air is supplied to the oxygenator 16 to add oxygen to the perfusate and adjust the pH of the perfusate.
The fluid is perfused through the arterial cannula 22 to the excised and preserved organ, and then perfused from the organ to the reservoir 10. The main part of the present invention is to arrange an artificial lung 16 (for example, a membrane lung) in the perfusate circuit configured as described above, which not only performs oxygen addition but also CO 2
The advantage is that the PH of the perfusate is also adjusted by controlling the gas partial pressure. As mentioned above, when the perfusate contains a bicarbonate-based PH buffer, the PH of the perfusate is calculated by the following formula (A) PH = 6.1 + log [HCO 3 - ] / [CO 2 ] ... (A ), and the value of [HCO 3 - ] hardly changes during perfusion, so it can be seen that the pH is uniquely determined by the value of [CO 2 ) in the perfusate. Will. Therefore, if you measure the [HCO 3 - ] value in the perfusate only at the beginning of the perfusion period, then the
It will also be seen that the PH can be determined by controlling only the CO 2 gas partial pressure. From this point of view, we use an oxygenator with a high CO 2 gas exchange ability, such that the partial pressure of CO 2 gas on the gas supply side of the oxygenator and the partial pressure of CO 2 gas in the perfusate can be almost equal. The organ preservation device of the present invention is configured to set the PH of the perfusate to a desired value by adjusting the mixing ratio (that is, the partial pressure of CO 2 gas in the mixed gas). Here, the present invention is theoretically considered as follows. First, the partial pressure of CO 2 gas in the perfusion fluid (hereinafter expressed as Pco 2 ) is: (1) The amount of CO 2 gas exchanged in the oxygenator: V 1 (2) From the organ storage chamber and reservoir in the perfusion circuit Amount of CO 2 released into the atmosphere: V 2 (3) Amount of CO 2 produced from preserved organs: V 3 In this case, the perfusate is being circulated so that it reaches equilibrium at a certain value. These relationships can be expressed as follows: V 1 = k 1 × S 1 × (P G - P L )/760 × α ... (B) V 2 = k 2 × S 2 × (- P L )/760×α ...(C) V 3 = so small that it can be ignored. [In the formula, k 1 is the CO 2 exchange coefficient in the oxygenator (cm/
S), k 2 is the CO 2 exchange coefficient between the liquid and the atmosphere (approximately 5 ×
10 -4 cm/S or less), S 1 is the membrane area of the oxygenator (cm 2 ), S 2 is the contact area between the perfusate and the atmosphere (the perfusate is usually about 1, and the contact area is about 200 cm 2 at maximum). ), P L is the value when Pco 2 in the perfusate reaches an equilibrium state.
CO 2 gas partial pressure [mmHg], P G is Pco 2 [mmHg] on the gas side of the oxygenator, α is CO 2 solubility [ml/ml.atom] (at 8℃,
1.18ml/ml.atom). Furthermore, after the Pco 2 of the perfusate reaches equilibrium, the equation
(D) V 1 + V 2 + V 3 = 0 ... (D) The following relationship holds true, and since V 3 is small and can be ignored as mentioned above, V 1 + V 2 ≒ 0 ... (D') becomes. By substituting the above equations (B) and (C) into V 1 and V 2 in the above equation (D'), the following equation (B) is obtained: k 1 ×S 1 ×(P G −PL )/ 760×1.18 −5×10 −4 ×200× PL /760×1.18=0 ∴PG / PL = (10 -1 ×k 1 S 1 )/k 1 S 1 ...(E) Here, P L (partial pressure of CO 2 on the oxygenator liquid side) increases as the oxygen exchange capacity increases.
(partial pressure of CO2 ), but never exactly the same value. If we assume that P L becomes equal to P G and the CO 2 molar concentration at that time is [CO 2 ]', then the PH' of the perfusate will be PH' = 6.1 according to the Henderson-Hasselbach equation (A). It is expressed as +log [HCO 3 - ]/[CO 2 ]' [PH target value when P G = P L ]. Furthermore, if the CO 2 molar concentration when the actual partial pressure of CO 2 on the oxygenator fluid side is P L is [CO 2 ], then the PH of the perfusate at that time is similarly calculated according to the Henderson-Hasselbach equation. It is expressed as PH″=6.1+log [HCO 3 ]/[CO 2 ]″ [actual PH value of perfusate]. From a physiological perspective, it is desirable that the PH of the perfusate be kept within a small deviation from the target PH value. Therefore, if the deviation between the PH target value and the actual PH value is ε, then |PH″−PH′|=ε PH″ and PH′ are the above Henderson equations, respectively.
Substituting the Hasselbach formula, we obtain the formula log[CO 2 ]′/[CO 2 ]″=±ε. Thus, the formula logP G /P L =±ε ∴P G /P L =10 ± 〓. If we want to keep the deviation ε within 0.05, that is, to keep the PH error within 0.05, since ε0.05 in the above equation, P G / PL 10 0 . 05 ∴P G / PL 1.1... ...(F). Therefore, from equations (E) and (F), 10 -1 +k 1 S 1 1.1×k 1 S 1 ∴k 1 S 1 1. Here, k 1 S 1 is nothing but the gas exchange capacity of the oxygenator used in the present invention.As can be seen from the above theoretical considerations, the PH of the perfusate
To set the CO2 of the oxygenator with an accuracy within 0.05
The gas exchange capacity should be 1 cm 3 /S per 100 ml/min of perfusate. As described above, according to the present invention, the PH of the perfusate can be determined by adjusting the mixing ratio of CO 2 and air (i.e., the CO 2 on the gas side of the oxygenator) without using a complicated PH electrode or measuring the PH over time. This is extremely advantageous in preserving excised organs using perfusate because it can be set to any desired value simply by adjusting the gas partial pressure). The present invention having the above configuration can be implemented as follows. First, according to the Henderson-Hatsselbach equation, PH=6.1+log[HCO 3 - ]/[CO 2 ]...(A), and from this equation (A), the equation [CO 2 ]=[HCO 3 - ] ×10 (6.1 - PH ) [mol/] ...(A′) is induced. In this formula (A'), [CO 2 ] is expressed as temperature t
When converted to gas partial pressure at °C, the following formula (G) Pco 2 (t °C) = [CO 2 ] [mol/l] x 10 -3 [/ml] / αt [ml (G) / ml( L). atm] × 22.4 × 10 3 [ml (G) / mol] × 760 [mmHg / atm] ... (G) [In the formula, ml (L) is the volume of the aqueous solution, ml (G) is the volume of CO 2 , αt is the solubility of CO 2 at t°C] is obtained. Furthermore, CO 2 on the gas side of the oxygenator
Regarding the gas partial pressure (Pco 2 ) and the flow rates of air and carbon dioxide (Qair, Qco 2 ), the following relational expressions (H) and (H') hold true. Qair: Qco 2 = (760−Pco 2 ): Pco 2 ……(H) Qco 2 = Qair × Pco 2 / (760−Pco 2 ) ……(H′) Above formulas (A′), (G) and From (H'), the following formula (I) Qco 2 (t℃) = [HCO 3 - ] x 10 ( 6.1- PH ) x 22.4 x 760/αt/760 - [HCO 3 - ] x 10 (
6
. 1- PH ) ×22.4×760/αt(ml/min.]...(I) is induced. The target PH value is expressed in the above formula (I), [HCO 3 - ]
The following Table 1 was obtained by substituting the values and the solubility α at each temperature.

【表】【table】

【表】 この第1表を使用することにより、潅流液のPH
を正確に設定しうることを確認した。 なお、第1表には目標PHを7.0〜7.5、潅流液温
度を4゜〜12℃、〔HCO3 -〕濃度を5〜25meqと
してCO2と空気との混合比を求めたが、上記各範
囲外においても前記諸式から同様な表を作成し、
それに従つて空気とCO2とを混合することにより
潅流液のPHを任意所望の値に設定しうることが了
解されよう。 また、図面に示した潅流液循環回路は、保存臓
器を収納する臓器保存室とリザーバとにおいて直
接大気に接触していることが了解されよう。
[Table] By using this Table 1, the PH of the perfusate can be determined.
It was confirmed that the settings could be set accurately. In addition, in Table 1, the mixing ratio of CO 2 and air was determined with the target pH of 7.0 to 7.5, the perfusate temperature of 4° to 12°C, and the [HCO 3 - ] concentration of 5 to 25 meq. Create a similar table from the above formulas even outside the range,
It will be appreciated that by mixing air and CO 2 accordingly, the PH of the perfusate can be set to any desired value. It will also be understood that the perfusate circulation circuit shown in the drawings is in direct contact with the atmosphere in the organ preservation chamber and reservoir that house preserved organs.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明による臓器保存装置のブロツク
図である。 10……リザーバ、12……潅流ポンプ、14
……熱交換器、16……人工肺、18……フイル
タ、20……エアトラツプ、22……動脈カニユ
ーレ、24……臓器保存室、26……炭酸ガス
源、28……エアポンプ、30,32……ガス流
量計、34……冷水ジヤケツト、36……冷却水
循環装置、38……ポンプ制御部、40……圧力
トランスジユーサ、42……増幅器、44……表
示器、46……記録計。
FIG. 1 is a block diagram of an organ preservation device according to the present invention. 10...Reservoir, 12...Irrigation pump, 14
... Heat exchanger, 16 ... Artificial lung, 18 ... Filter, 20 ... Air trap, 22 ... Arterial cannula, 24 ... Organ storage chamber, 26 ... Carbon dioxide gas source, 28 ... Air pump, 30,32 ... Gas flow meter, 34 ... Cold water jacket, 36 ... Cooling water circulation device, 38 ... Pump control unit, 40 ... Pressure transducer, 42 ... Amplifier, 44 ... Display, 46 ... Recorder .

Claims (1)

【特許請求の範囲】 1 摘出した臓器に、重炭酸系のPH緩衝剤を含有
する液体を潅流させて臓器の活性を維持しつつ臓
器を保存する摘出臓器の保存装置において、前記
液体の潅流回路中にCO2ガス交換能の高い人工肺
を設け、この人工肺のガス側におけるCO2と空気
との混合比を調整することにより前記液体のPHを
オープンループにより制御するよう構成したこと
を特徴とする臓器保存装置。 2 人工肺のCO2ガス交換能が潅流液100ml/min.
当り1cm3/S以上であることを特徴とする特許請
求の範囲第1項記載の臓器保存装置。
[Scope of Claims] 1. A preservation device for an extracted organ that preserves the organ while maintaining the activity of the organ by perfusing the extracted organ with a liquid containing a bicarbonate-based PH buffer, comprising: a perfusion circuit for the liquid; An oxygenator with a high CO 2 gas exchange capacity is installed inside the oxygenator, and the pH of the liquid is controlled in an open loop by adjusting the mixing ratio of CO 2 and air on the gas side of the oxygenator. An organ preservation device. 2. The CO 2 gas exchange capacity of the oxygenator is 100ml/min of perfusate.
2. The organ preservation device according to claim 1, wherein the organ storage capacity is 1 cm 3 /S or more.
JP8012682A 1982-05-14 1982-05-14 Apparatus for preserving internal organ Granted JPS58198401A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8012682A JPS58198401A (en) 1982-05-14 1982-05-14 Apparatus for preserving internal organ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8012682A JPS58198401A (en) 1982-05-14 1982-05-14 Apparatus for preserving internal organ

Publications (2)

Publication Number Publication Date
JPS58198401A JPS58198401A (en) 1983-11-18
JPS6155883B2 true JPS6155883B2 (en) 1986-11-29

Family

ID=13709519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8012682A Granted JPS58198401A (en) 1982-05-14 1982-05-14 Apparatus for preserving internal organ

Country Status (1)

Country Link
JP (1) JPS58198401A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0333562U (en) * 1989-08-10 1991-04-02

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0333562U (en) * 1989-08-10 1991-04-02

Also Published As

Publication number Publication date
JPS58198401A (en) 1983-11-18

Similar Documents

Publication Publication Date Title
AU2023203083B2 (en) Systems and methods for ex vivo lung care
Agostoni et al. Absorption force of the capillaries of the visceral pleura in determination of the intrapleural pressure
Fegler Measurement of cardiac output in anaesthetized animals by a thermo‐dilution method
Curtis et al. An improved perfusion apparatus for small animal hearts
Chapin Ventilatory response of the unrestrained and unanesthetized hamster to CO2
Emilio et al. Gas exchange and its effect on blood gas concentrations in the amphibian, Xenopus laevis
Reeves et al. Pulmonary circulation and oxygen transport in lambs at high altitude
Wang et al. Influence of temperature of flushing solution on lung preservation
Uhlig The isolated perfused lung
JPS6155883B2 (en)
Davies et al. Effect of body temperature on ventilatory control in the alligator
DuBois et al. CO2 dissociation curve of lung tissue
Gemer et al. Pulmonary insufficiency induced by oleic acid in the sheep: a model for investigation of extracorporeal oxygenation
Scheid et al. Gas-blood CO 2 equilibration in dog lungs during rebreathing.
Salzano et al. Effect of hypothermia on ventilatory response to carbon dioxide inhalation and carbon dioxide infusion in dogs
Burns et al. DLO2 in excised lungs perfused with blood containing sodium dithionite (Na2S2O4)
Carter et al. Respiratory effects of carbonic anhydrase inhibition in the trained unanesthetized dog
Karabulut et al. Adjustment of sweep gas flow during cardiopulmonary bypass
Nadybal et al. Detecting pulmonary edema throughout ex vivo lung perfusion
US20260101885A1 (en) Negative pressure ventilation assisted ex vivo lung preservation system
van der Linden et al. Middle cerebral artery flow velocity during coronary surgery; influence of clinical variables
Niden et al. Pulmonary diffusion in the dog lung
Riley et al. Alpha-stat and pH-stat management techniques in artificial blood oxygenators
Williams et al. Hyperbaric oxygenation: influence on coronary blood flow and oxygen delivery to the myocardium
Prakash Hypothermia and acid-base regulation in infants